LawPlayer
My bookmarksSign up freeSign up free
Source

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

2009/752/EC: Commission Decision of 12 October 2009 authorising the placing on the market of a lipid extract from Antarctic Krill Euphausia superba as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2009) 7647)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Lipid extract from Antarctic Krill Euphausia superba as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for the uses and at the maximum levels as listed in Annex II.

Article 2

Open ↗

The designation ‘lipid extract from the crustacean Antarctic Krill Euphausia superba ’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.

Article 3

Open ↗

This Decision is addressed to Neptune Technologies & Bioressources Inc., 225 Promenade du Centropolis, Suite 200, Laval, Quebec H7T 0B3, Canada.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I SPECIFICATION OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA Description To produce lipid extract from Antarctic Krill Euphausia superba deep-frozen Antarctic krill is crushed and subjected to an extraction with acetone. Proteins and krill material are removed from the lipid extract by filtration. The acetone and residual water are removed by evaporation. Test Specification Saponification value Not more than 185 mg KOH/g Peroxide value (PV) Not more than 0,2 meq O 2 /kg oil Moisture and volatiles Not more than 0,9 % Phospholipids Not more than 50 % Trans-fatty acids Not more than 1 % EPA (eicosapentaenoic acid) Not less than 15 % DHA (docosahexaenoic acid) Not less than 7 %

ANNEX IISupplementary provisions

Open ↗

ANNEX II USES OF LIPID EXTRACT FROM ANTARCTIC KRILL EUPHAUSIA SUPERBA Use group Maximum content of combined DHA and EPA Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g Spreadable fat and dressings 600 mg/100 g Breakfast cereals 500 mg/100 g Food supplements 200 mg per daily dose as recommended by the manufacturer Dietary foods for special medical purposes In accordance with the particular nutritional requirements of the persons for whom the products are intended Foods intended for use in energy restricted diets for weight reduction 200 mg/meal replacement

Other acts of the same type
Council Decision (CFSP) 2025/781 of 14 April 2025 in support of the Siem Reap-Angkor Action Plan for the implementation of the 1997 Convention on the Prohibition of the Use, Stockpiling, Production and Transfer of Anti-Personnel Mines and on their DestructionCommission Implementing Decision (EU) 2025/784 of 14 April 2025 amending Implementing Decision (EU) 2024/3238 concerning certain emergency measures relating to infection with peste des petits ruminants virus in Bulgaria (notified under document C(2025) 2349)Commission Implementing Decision (EU) 2025/785 of 14 April 2025 amending Implementing Decision (EU) 2025/638 concerning certain emergency measures relating to infection with peste des petits ruminants virus in Romania (notified under document C(2025) 2350)Decision (EU) 2025/793 of the European Parliament and of the Council of 14 April 2025 providing macro-financial assistance to the Hashemite Kingdom of JordanCommission Implementing Decision (EU) 2025/795 of 14 April 2025 amending the Annex to Implementing Decision (EU) 2025/672 concerning certain emergency measures relating to outbreaks of foot and mouth disease in Hungary and Slovakia (notified under document C(2025) 2427)Council Decision (EU) 2025/798 of 14 April 2025 on the signing, on behalf of the Union, of the Agreement on Digital Trade between the European Union and the Republic of SingaporeCouncil Decision (EU) 2025/799 of 14 April 2025 establishing the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the adoption of a decision adding a newly adopted Union act to Annex 2 to the Windsor FrameworkCouncil Decision (EU) 2025/800 of 14 April 2025 establishing the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the adoption of a decision adding a newly adopted Union act to Annex 2 to the Windsor FrameworkCouncil Decision (EU) 2025/802 of 14 April 2025 establishing the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the declaration to be made pursuant to Article 23(5)(a) of Decision No 1/2023 of the Joint CommitteeCouncil Implementing Decision (EU) 2025/816 of 14 April 2025 authorising Italy to apply, in determined geographical areas, reduced rates of taxation on gas oil and liquid petroleum gas used for heating purposesCouncil Decision (EU) 2025/851 of 14 April 2025 on the conclusion, on behalf of the Union, of the Agreement between Canada and the European Union on the transfer and processing of Passenger Name Record dataCouncil Implementing Decision (EU) 2025/852 of 14 April 2025 authorising the Slovak Republic to introduce a special measure derogating from Article 26(1), point (a), and Articles 168 and 168a of Directive 2006/112/EC on the common system of value added tax

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next